Enable Injections develops the enFuse wearable drug delivery platform, which allows patients to self-administer large volumes of medication subcutaneously through a hands-free system. This technology provides a more comfortable and convenient alternative to intravenous administration, enhancing the patient treatment experience.
Funding
$215M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MCFounders
Product
Problem
Many patients require frequent administration of large-volume medications, which traditionally necessitates intravenous infusions, leading to discomfort, inconvenience, and increased healthcare costs. Repeated clinic visits for IV therapy can disrupt daily life and pose challenges for patients with limited mobility or those residing far from treatment centers.
Solution
Enable Injections offers the enFuse® platform, a wearable, hands-free drug delivery system designed for comfortable subcutaneous administration of high-volume medications. This innovative technology allows patients to self-administer treatments outside of a clinical setting, reducing the need for frequent intravenous infusions. The enFuse® system simplifies the delivery process through a simple injection under the skin, enhancing patient autonomy and improving the overall treatment experience. By enabling convenient, at-home administration, Enable Injections aims to improve adherence, reduce healthcare costs, and empower patients to manage their conditions more effectively. The platform is also designed to integrate with various therapies, offering pharmaceutical partners a versatile solution for drug delivery.
Target Audience
The primary target audience includes patients requiring frequent, large-volume medication delivery, pharmaceutical companies seeking innovative drug delivery solutions, and healthcare providers aiming to improve patient outcomes and reduce healthcare costs.
Features
- Wearable, hands-free design for convenient subcutaneous administration
- Capability to deliver large-volume medications, reducing the need for IV infusions
- Compatibility with a range of drug therapies, offering versatility for pharmaceutical partners
- Patient-centric design focused on comfort and ease of use
- Integration with smart technology for enhanced monitoring and control
- Streamlined manufacturing process ensuring high-quality and reliable devices
- Regulatory CE Mark approval in Europe